GO
Loading...

Pfizer Inc

More

  • Final Glance: Pharmaceuticals companies Friday, 24 Oct 2014 | 6:35 PM ET

    Baxter International Inc. rose$. 73 or 1.1 percent, to $69.83. Bristol-Myers Squibb Co. rose $1.13 or 2.2 percent, to $53.63. Hospira rose$. 80 or 1.6 percent, to $52.25.

  • Midday Glance: Pharmaceuticals companies Friday, 24 Oct 2014 | 1:17 PM ET

    Baxter International Inc. rose$. 64 or. 9 percent, to $69.74. Bristol-Myers Squibb Co. rose $1.00 or 1.9 percent, to $53.50. Hospira rose$. 48 or. 9 percent, to $51.93.

  • Most active New York Stock Exchange-traded stocks Friday, 24 Oct 2014 | 1:17 PM ET

    NEW YORK— A look at New York Stock Exchange 10 most-active stocks at the close of trading:. AT&T Inc. rose. 6 percent to $33.87 with 28,797,000 shares traded. Bank of America Corp. rose. 7 percent to $16.72 with 39,556,100 shares traded.

  • Oct 24- Drugmaker Baxter International Inc said the U.S. Food and Drug Administration had approved its drug for treating bleeding episodes in adults with a rare bleeding disorder. Obizur will compete with Biogen Idec Inc's Eloctate, which was approved in June. Other approved hemophilia B treatments include Baxter's Rixubis, Pfizer Inc's Benefix and CSL...

  • Early Glance: Pharmaceuticals companies Friday, 24 Oct 2014 | 10:40 AM ET

    Baxter International Inc. rose$. 67 or 1.0 percent, to $69.77. Bristol-Myers Squibb Co. rose $1.28 or 2.4 percent, to $53.78. Hospira rose$. 36 or. 7 percent, to $51.81.

  • Rapid UK economic growth slows slightly in 3rd quarter. LONDON- Britain's rapid economic recovery eased as expected during the third quarter, as services output growth slowed and manufacturing expanded at the weakest pace in 18 months, official data shows. BRUSSELS- France and Italy make fresh commitments to reform to persuade Germany and the European...

  • Final Glance: Pharmaceuticals companies Thursday, 23 Oct 2014 | 6:02 PM ET

    Baxter International Inc. rose$. 73 or 1.1 percent, to $69.10. Bristol-Myers Squibb Co. rose$. 66 or 1.3 percent, to $52.50. Hospira rose $1.37 or 2.7 percent, to $51.45.

  • After-hours buzz: Amazon, Microsoft, Pfizer & more Thursday, 23 Oct 2014 | 5:00 PM ET

    Check out which companies are making headlines after the bell Thursday: Amazon, Microsoft, Pfizer & more.

  • Pfizer approves $11B stock repurchase plan Thursday, 23 Oct 2014 | 4:32 PM ET

    NEW YORK— Drugmaker Pfizer says it approved the repurchase of $11 billion in company stock. Pfizer has $1.3 billion remaining from its latest stock repurchase program. Pfizer Inc. is the world's second-largest drugmaker, and its products include the vaccine Prevnar and pain and fibromyalgia treatment Lyrica.

  • Most active New York Stock Exchange-traded stocks Thursday, 23 Oct 2014 | 1:51 PM ET

    NEW YORK— A look at New York Stock Exchange 10 most-active stocks at the close of trading:. AT&T Inc. fell 2.4 percent to $33.66 with 54,340,400 shares traded. Advanced Micro Devices Inc. rose 1.9 percent to $2.69 with 23,669,400 shares traded.

  • Midday Glance: Pharmaceuticals companies Thursday, 23 Oct 2014 | 1:51 PM ET

    Baxter International Inc. rose$. 72 or 1.1 percent, to $69.09. Bristol-Myers Squibb Co. rose$. 49 or. 9 percent, to $52.33. Hospira rose $1.12 or 2.2 percent, to $51.20.

  • Midday movers: Deere, GrubHub, Lazard, Pfizer & more Thursday, 23 Oct 2014 | 12:50 PM ET

    Some of Thursday's midday movers:

  • Early Glance: Pharmaceuticals companies Thursday, 23 Oct 2014 | 11:56 AM ET

    Baxter International Inc. rose$. 59 or. 9 percent, to $68.96. Bristol-Myers Squibb Co. rose$. 36 or. 7 percent, to $52.20. Hospira rose$. 74 or 1.5 percent, to $50.82.

  • U.S. court upholds patents on Pfizer's cancer drug Thursday, 23 Oct 2014 | 8:57 AM ET

    Oct 23- A U.S. district court ruled in favor of Pfizer Inc in a patent lawsuit it filed against Mylan Inc alleging patent infringement on its cancer drug, Sutent, Pfizer said. Pfizer filed the lawsuit in June 2010 after Mylan attempted to market a generic version of Sutent, patented until 2021.. The case is Pfizer Inc v.

  • Final Glance: Pharmaceuticals companies Wednesday, 22 Oct 2014 | 6:09 PM ET

    Baxter International Inc. fell$. 28 or. 4 percent, to $68.37. Bristol-Myers Squibb Co. fell$. 11 or. 2 percent, to $51.84. Hospira fell$. 80 or 1.6 percent, to $50.08.

  • Most active New York Stock Exchange-traded stocks Wednesday, 22 Oct 2014 | 1:18 PM ET

    NEW YORK— A look at New York Stock Exchange 10 most-active stocks at the close of trading:. Alcoa Inc. fell 1.4 percent to $16.12 with 27,031,800 shares traded. Bank of America Corp. fell 1.2 percent to $16.40 with 84,020,900 shares traded.

  • Midday Glance: Pharmaceuticals companies Wednesday, 22 Oct 2014 | 1:18 PM ET

    Baxter International Inc. fell$. 24 or. 3 percent, to $68.41. Bristol-Myers Squibb Co. fell$. 01 or percent, to $51.94. Hospira rose$. 09 or. 2 percent, to $50.97.

  • *Exploring IPO of minority stake in ViiV Healthcare. LONDON, Oct 22- GlaxoSmithKline, battered by weak U.S. drug sales and a bribery scandal in China, is looking to float its fast-growing HIV drugs business as part of a recovery plan that includes a fresh round of cost cutting. As a standalone company ViiV Healthcare would be among the top 40 companies in London's...

  • Early Glance: Pharmaceuticals companies Wednesday, 22 Oct 2014 | 10:36 AM ET

    Baxter International Inc. rose$. 17 or. 2 percent, to $68.82. Bristol-Myers Squibb Co. rose$. 02 or percent, to $51.97. Hospira rose$. 06 or. 1 percent, to $50.94.

  • *Exploring IPO of minority stake in ViiV Healthcare. LONDON, Oct 22- GlaxoSmithKline, battered by weak U.S. drug sales and a bribery scandal in China, set out a bold recovery plan on Wednesday, including an initial public offering of part of its fast-growing HIV and AIDS drugs business. As a standalone company ViiV Healthcare would be among the top 40 companies in...